Cystic fibrosis.
Cystic fibrosis.
复制标题
DOI:
10.1038/nrdp.2015.10
复制
发表时间:
2015-05-14
期刊:
影响因子:
--
通讯作者:
Bush A
中科院分区:
文献类型:
--
作者:
Ratjen F;Bell SC;Rowe SM;Goss CH;Quittner AL;Bush A
Cystic fibrosis is an autosomal-recessive, monogenetic disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. The gene defect was first described 25 years ago and much progress has been made since then in our understanding on how CFTR mutations cause disease and how this can be addressed therapeutically. CFTR is a transmembrane protein that transports ions across the surface of epithelial cells. CFTR dysfunction affects many organs; however, lung disease is responsible for the vast majority of morbidity and mortality in patients with cystic fibrosis. Prenatal diagnostics, newborn screening and new treatment algorithms are changing the incidence and prevalence of the disease. Until recently, the standard of care in cystic fibrosis treatment focused on preventing and treating complications of the disease; now, novel treatment strategies targeting the ion channel abnormality directly are becoming available and it will be important to evaluate how these treatments affect disease progression and quality of life of patients. In this Primer, we summarize the current knowledge and provide an outlook on how cystic fibrosis clinical care and research will be affected by new knowledge and therapeutic options in the near future.
登录
查看更多内容
影响因子:
10
作者:
Amin, Reshma;Subbarao, Padmaja;Ratjen, Felix
通讯作者:
Ratjen, Felix
DOI:
10.1085/jgp.200709781
发表时间:
2007-12
期刊:
The Journal of general physiology
影响因子:
--
作者:
Adebamiro A;Cheng Y;Rao US;Danahay H;Bridges RJ
通讯作者:
Bridges RJ
DOI:
10.1164/rccm.201404-0670oc
发表时间:
2014-08-15
影响因子:
24.7
作者:
Birket, Susan E.;Chu, Kengyeh K.;Rowe, Steven M.
通讯作者:
Rowe, Steven M.
影响因子:
24.5
作者:
Blondeau, K.;Dupont, L. J.;Sifrim, D.
通讯作者:
Sifrim, D.
影响因子:
5.4
作者:
Boyle, Michael P.;Sabadosa, Kathryn A.;Schechter, Michael S.
通讯作者:
Schechter, Michael S.